Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1. 1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2. 2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3. 3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4. 4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5. 5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6. 6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.